New device could ease chronic constipation without drugs
NCT ID NCT06833684
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called MOWOOT that uses gentle pulses to help the colon move stool in adults with long-term constipation. About 40 people who are waiting for another treatment (trans-anal irrigation) will try the device daily for a period. The goal is to see if it improves their bowel-related quality of life and satisfaction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adult people (18 yo or older) of any gender 2. Attending their pre-scheduled on-site visit to the site (The Sir Alan Parks Physiology \& Pelvic Floor Biofeedback Unit \| Central Middlesex Hospital) due to constipation (Symptoms meeting the American College of Gastroenterology definition of chronic constipation: unsatisfactory defaecation characterized by infrequent stool, difficult stool passage or both for at least previous 3 months. 3. Bothered by their constipation 4. Failed biofeedback (in absence of outlet problems) 5. In waiting list to use TAI 6. Able to undertake the treatment with the MOWOOT device or TAI themselves, or with a carer willing to do it 7. Able to understand the study requirements 8. Able to understand written and spoken English (due to questionnaire validity) 9. Able and willing to provide written informed consent to participate Exclusion Criteria: A subject will not be eligible for inclusion in this study if any of the following criteria apply: Disease phenotype exclusion criteria: * Irritable Bowel Syndrome with Diarrhoea (IBS-D) or alternating constipation and diarrhoea (IBSmix): (not due to laxative use) * Inflammatory Bowel Disease (IBD) * Significant outlet problem * Trapping rectocele * Intra anal rectal intussusception * External rectal prolapse Device-related exclusion criteria: * Abdominal perimeter ≤65cm or ≥130cm * Unable to independently use the MOWOOT technology, unless a carer is available daily to assist Other medical conditions, medications and contraindications: * Pregnancy or attempt to become pregnant in the next 6 months. * Previous large bowel resection * Active anorexia or bulimia * Active abdominal cancer * Large inguinal or umbilical hernia * Recent abdominal scars, abdominal wounds or skin disorders that may make abdominal massage uncomfortable * Any condition that contraindicates abdominal massage. * Significant abdominal pain * Participation in another parallel interventional clinical trial or less than 2 months from participation in a previous interventional clinical trial * Planned surgery\* if it might be within trial dates (\* minor surgery not affecting adherence to treatment is allowed)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Constipation chronic idiopathic are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Sir Alan Parks Physiology & Pelvic Floor Biofeedback Unit., Central Hospital, Department of Physiology, St Mark's Hospital, The National Bowel Hospital
RECRUITINGLondon, London, NW10 7NS, United Kingdom
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.